Diagnos: Discover the Unseeable with CARA

Diagnos is rolling out their non-invasive AI health care technology to prescreen for diabetes-related blindness. This disruptive AI technology platfor …

September 30, 2021
Request Investor InfoRequest Investor Info
Diagnos

A leader in artificial intelligence and healthcare technical services including algorithm development, data analysis, and image processing ever since 2001

Diagnos is rolling out their non-invasive AI health care technology to prescreen for diabetes-related blindness. This disruptive AI technology platform works seamlessly with current optometry equipment in a global market expected to double.

They have a product called CARA used for computer-assisted retinal analyses. What this product does is automatically analyze the retina, and it can spot damage caused by diabetes or cardiovascular issues. That said, Cara can actually save someone from going blind.

For more information on Diagnos (TSX.V: ADK) please click the request investor info button.

stock market
stock picks
stocks
stocks to buy

You might also like

Brompton Funds: BGIE - Investing in What the World Can’t Do Without
ETFs
June 11, 2026

Brompton Funds: BGIE - Investing in What the World Can’t Do Without

Brompton’s Global Infrastructure ETF offers investors access to key infrastructure stocks supporting the world’s critical systems.

This is some text inside of a div block.
Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?
Finance
June 10, 2026

Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?

This is some text inside of a div block.
Brompton Funds
ETFs
June 10, 2026

Brompton Funds: Enhanced Multi-Asset Income ETF - BMAX

BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

This is some text inside of a div block.
Subscribe and receive the investor Info